- For Patients
- Introduction to the Marshall Protocol
- Length of the MP
- Immunopathology
- Managing immunopathology
- Food and drink
- Light restriction
- Vitamin D metabolite calculator - get feedback on vitamin D results
- Therapeutic probe - best method for determining MP suitability
- Starting the Marshall Protocol
- Resources for patients
- Marshall Protocol summary
- Palliative vs. curative treatments
- Patient interviews on Bacteriality
- Non-MP treatments
- Glossary
- The Protocol
- Marshall Protocol summary
- Publications and presentations
- Science behind immunopathology
- Science behind olmesartan (Benicar)
- Safety of olmesartan
- Resources for physicians
- Vitamin D metabolite calculator - get feedback on vitamin D results
- Therapeutic probe - best method for determining MP suitability
- Physicians' concerns about the MP
- Notice for emergency medical personnel
- The Pathogenesis
- Publications and presentations
- Science behind Marshall Pathogenesis
- Microbes in the human body
- Successive infection and variability in disease
- Autoimmune theory of disease
- Science behind vitamin D
- Metabolism of vitamin D and the VDR
- Th1 Spectrum Disorder - how chronic inflammatory diseases are related
- Transmission of bacteria and onset of chronic disease
- Evolutionary perspective on disease
- Incidence and prevalence of disease
- Evidence that chronic disease is caused by pathogens
- Diseases
- Foundation
- Related Sites
Differences
This shows you the differences between two versions of the page.
| Both sides previous revisionPrevious revisionNext revision | Previous revision | ||
| playground:template [07.02.2019] – [text] sallieq | playground:template [09.14.2022] (current) – external edit 127.0.0.1 | ||
|---|---|---|---|
| Line 13: | Line 13: | ||
| === WIP === | === WIP === | ||
| - | //**authors** et al.//(({{pubmed>long:88888888}})) | + | //**Bolland, MJ** et al.//(({{pmid>long:26420387}})) |
| Line 35: | Line 35: | ||
| < | < | ||
| - | insert | + | Cardiovascular complications of calcium supplements. |
| - | //**MJ Bolland and IR Reid**// (({{pubmed> | + | //**MJ Bolland and IR Reid**// (({{pmid> |
| </ | </ | ||
| Line 76: | Line 76: | ||
| + | < | ||
| ===== Notes and comments ===== | ===== Notes and comments ===== | ||
| Line 81: | Line 82: | ||
| =====References===== | =====References===== | ||
| + | </ | ||
playground/template.1562042599.txt.gz · Last modified: 07.02.2019 by sallieq
© 2015, Autoimmunity Research Foundation. All Rights Reserved.